Retrospective Epidemiological Study of Lung Cancer With Low-dose Multislice Computed Tomography
NCT ID: NCT02736643
Last Updated: 2019-01-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1334 participants
OBSERVATIONAL
2016-04-30
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
National Taiwan University Hospital Chu-Tung Branch (NTUHCT) initiated the lung cancer screening by LDCT since June 2015. Many people can get the LDCT screening with affordable price with the subsidy from enterprise donation. The purpose of this study is establishing local epidemiological result via telephone follow-up and patients' medical records retrospectively.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early Detection of Lung Cancer With Low-dose Multislice Computed Tomography
NCT02754388
Low-dose Computed Tomography Screening for Lung Cancer in Relatives With Family History of Lung Cancer
NCT02519972
Image Discovering Early Lung Cancer Project
NCT01914458
LDCT Screening in Non-smokers in Taiwan
NCT02611570
Specimen and Clinical Data Collection Plan for LDCT Screening Participants
NCT07048236
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
National Taiwan University Hospital Chu-Tung Branch (NTUHCT) initiated the lung cancer screening by LDCT since June 2015. Many people can get the LDCT screening with affordable price with the subsidy from enterprise donation. The purpose of this study is establishing local epidemiological result via telephone follow-up and patients' medical records retrospectively.
Aim: To establish the local epidemiological data for lung pathology, emphysema, bronchiectasis and other lung disease.
Methods: Since June 2015, more than 6000 LDCT were done at the NTUHCT. Roughly 6 months after the test telephone follow-ups about patient satisfactions, self-awareness of CT results, medical consultations and other related behaviors, and willingness of coming back for another test were routinely done. Retrospective secondary data analysis will be performed on the telephone follow-up results to establish local epidemiology data on lung pathology as well as information on screening accuracy of LDCT. Customers are also queried about willingness to provide their medical records, and linkage to National Health Insurance Database with informed consents to provide more advanced information on their long-term outcomes.
Keywords: Lung cancer, Low dose computed tomography, screening.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
OTHER
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
20 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Taiwan University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ding-Cheng Chan, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
National Taiwan University Hospital Chu-Tung Branch
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
201601052RINB
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.